ENTRY       D02531            Mixture   Drug
NAME        Bacitracin zinc, neomycin sulfate and polymixin B sulfate;
            Neosporin (TN)
PRODUCT     NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC (Casper Pharma LLC)
  GENERIC   NEO POLYCIN (Padagis US LLC)
            NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC (Bausch & Lomb Incorporated)
            NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC (Rising Pharma Holdings)
            NEOMYCIN AND POLYMYXIN B SULFATES, AND BACITRACIN ZINC (Akorn)
            NEOMYCIN AND POLYMYXIN B SULFATES, AND BACITRACIN ZINC (Henry Schein)
            NEOMYCIN AND POLYMYXIN B SULFATES, AND BACITRACIN ZINC (MWI)
COMPONENT   Bacitracin zinc [DR:D03048], Neomycin sulfate [DR:D01618], Polymixin B sulfate [DR:D01066]
REMARK      Product: D02531<US>
EFFICACY    Antibiotic (topical)
  DISEASE   Blepharitis [DS:H01644]
COMMENT     Fradiomycin sulfate B (R1 = -H, R2 = -CH2NH2)
            Fradiomycin sulfate C (R1 = -CH2NH2, R2 = -H)
BRITE       USP drug classification [BR:br08302]
             Ophthalmic Agents
              Ophthalmic Agents, Combinations
               Neomycin/ Polymyxin B Sulfate/ Bacitracin Zinc
                D02531  Bacitracin zinc, neomycin sulfate and polymixin B sulfate
            Antimicrobials [BR:br08307]
             Antibacterials
              Protein biosynthesis inhibitor
               Aminoglycoside
                D02531  Bacitracin zinc, neomycin sulfate and polymixin B sulfate &lt;US&gt;
DBLINKS     PubChem: 47205809
///
